Cargando…

Microvascular differences in individuals with obesity at risk of developing cardiovascular disease

OBJECTIVE: This study aimed to investigate microvascular differences in individuals with obesity at risk for developing cardiovascular disease. METHODS: In this cross‐sectional Netherlands Epidemiology of Obesity study, participant sublingual microcirculation was assessed with a newly developed Glyc...

Descripción completa

Detalles Bibliográficos
Autores principales: van der Velden, Anouk I. M., van den Berg, Bernard M., de Mutsert, Renée, van der Vlag, Johan, Jukema, J. Wouter, Rosendaal, Frits R., Rabelink, Ton J., Vink, Hans
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8456841/
https://www.ncbi.nlm.nih.gov/pubmed/34338418
http://dx.doi.org/10.1002/oby.23222
_version_ 1784570951490338816
author van der Velden, Anouk I. M.
van den Berg, Bernard M.
de Mutsert, Renée
van der Vlag, Johan
Jukema, J. Wouter
Rosendaal, Frits R.
Rabelink, Ton J.
Vink, Hans
author_facet van der Velden, Anouk I. M.
van den Berg, Bernard M.
de Mutsert, Renée
van der Vlag, Johan
Jukema, J. Wouter
Rosendaal, Frits R.
Rabelink, Ton J.
Vink, Hans
author_sort van der Velden, Anouk I. M.
collection PubMed
description OBJECTIVE: This study aimed to investigate microvascular differences in individuals with obesity at risk for developing cardiovascular disease. METHODS: In this cross‐sectional Netherlands Epidemiology of Obesity study, participant sublingual microcirculation was assessed with a newly developed GlycoCheck software (Microvascular Health Solutions Inc., Salt Lake City, Utah), which integrates red blood cell velocity within the smallest capillaries (4‐7 µm) and feed vessels (>10 µm). Framingham Risk Score was used to calculate 10‐year cardiovascular risk, divided into low‐, intermediate‐, and high‐risk groups. ANOVA was used to evaluate microvascular differences among the groups. RESULTS: A total of 813 participants were included. The high‐risk group (n = 168) was characterized by differences in the microvasculature compared with the low‐risk group (n = 392): the high‐risk group had a 49% reduction in the number of smallest capillaries and a 9.1‐µm/s (95% CI: 5.2‐12.9) higher red blood cell velocity in the feed vessels. No differences in velocity‐corrected perfused boundary regions were found. CONCLUSIONS: It was observed that, with adding red blood cell velocity to the software, sidestream dark field imaging is able to detect microcirculatory differences in a cohort of individuals with obesity at risk for developing cardiovascular disease.
format Online
Article
Text
id pubmed-8456841
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-84568412021-09-27 Microvascular differences in individuals with obesity at risk of developing cardiovascular disease van der Velden, Anouk I. M. van den Berg, Bernard M. de Mutsert, Renée van der Vlag, Johan Jukema, J. Wouter Rosendaal, Frits R. Rabelink, Ton J. Vink, Hans Obesity (Silver Spring) BRIEF CUTTING EDGE REPORTS OBJECTIVE: This study aimed to investigate microvascular differences in individuals with obesity at risk for developing cardiovascular disease. METHODS: In this cross‐sectional Netherlands Epidemiology of Obesity study, participant sublingual microcirculation was assessed with a newly developed GlycoCheck software (Microvascular Health Solutions Inc., Salt Lake City, Utah), which integrates red blood cell velocity within the smallest capillaries (4‐7 µm) and feed vessels (>10 µm). Framingham Risk Score was used to calculate 10‐year cardiovascular risk, divided into low‐, intermediate‐, and high‐risk groups. ANOVA was used to evaluate microvascular differences among the groups. RESULTS: A total of 813 participants were included. The high‐risk group (n = 168) was characterized by differences in the microvasculature compared with the low‐risk group (n = 392): the high‐risk group had a 49% reduction in the number of smallest capillaries and a 9.1‐µm/s (95% CI: 5.2‐12.9) higher red blood cell velocity in the feed vessels. No differences in velocity‐corrected perfused boundary regions were found. CONCLUSIONS: It was observed that, with adding red blood cell velocity to the software, sidestream dark field imaging is able to detect microcirculatory differences in a cohort of individuals with obesity at risk for developing cardiovascular disease. John Wiley and Sons Inc. 2021-08-02 2021-09 /pmc/articles/PMC8456841/ /pubmed/34338418 http://dx.doi.org/10.1002/oby.23222 Text en © 2021 The Authors. Obesity published by Wiley Periodicals LLC on behalf of The Obesity Society (TOS) https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle BRIEF CUTTING EDGE REPORTS
van der Velden, Anouk I. M.
van den Berg, Bernard M.
de Mutsert, Renée
van der Vlag, Johan
Jukema, J. Wouter
Rosendaal, Frits R.
Rabelink, Ton J.
Vink, Hans
Microvascular differences in individuals with obesity at risk of developing cardiovascular disease
title Microvascular differences in individuals with obesity at risk of developing cardiovascular disease
title_full Microvascular differences in individuals with obesity at risk of developing cardiovascular disease
title_fullStr Microvascular differences in individuals with obesity at risk of developing cardiovascular disease
title_full_unstemmed Microvascular differences in individuals with obesity at risk of developing cardiovascular disease
title_short Microvascular differences in individuals with obesity at risk of developing cardiovascular disease
title_sort microvascular differences in individuals with obesity at risk of developing cardiovascular disease
topic BRIEF CUTTING EDGE REPORTS
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8456841/
https://www.ncbi.nlm.nih.gov/pubmed/34338418
http://dx.doi.org/10.1002/oby.23222
work_keys_str_mv AT vanderveldenanoukim microvasculardifferencesinindividualswithobesityatriskofdevelopingcardiovasculardisease
AT vandenbergbernardm microvasculardifferencesinindividualswithobesityatriskofdevelopingcardiovasculardisease
AT demutsertrenee microvasculardifferencesinindividualswithobesityatriskofdevelopingcardiovasculardisease
AT vandervlagjohan microvasculardifferencesinindividualswithobesityatriskofdevelopingcardiovasculardisease
AT jukemajwouter microvasculardifferencesinindividualswithobesityatriskofdevelopingcardiovasculardisease
AT rosendaalfritsr microvasculardifferencesinindividualswithobesityatriskofdevelopingcardiovasculardisease
AT rabelinktonj microvasculardifferencesinindividualswithobesityatriskofdevelopingcardiovasculardisease
AT vinkhans microvasculardifferencesinindividualswithobesityatriskofdevelopingcardiovasculardisease